The Hidden Dangers of Cough Syrup Misuse in Infants in Pakistan: A Call for Awareness and Regulation

Authors

  • Maha Ahmed Shaheed Mohtarma Benazir Bhutto Medical College Lyari Author

DOI:

https://doi.org/10.63501/k1ck7c63

Abstract

CCMs (Cough and cold medications) are an issue of increasing healthcare concern thrown in the face of misuse in infants. It is among the growing concerns and often underestimated in Pakistan. There are various health authorities worldwide beyond ban from the FDA from CCM use in infants below two years, yet they continue to be misused given ignorance, easy availability, and cultural practices. "The incidence of accidents and unsupervised ingestion is alarmingly rising," says a study. It makes children suffer from symptoms like tachycardia, which sometimes leads to death in the worst cases. The letter pleads for urgent public health awareness, regulatory enforcement, and better labeling to protect the tender pediatric population in this regard from avoidable injury.

Dextromethorphan and diphenhydramine are cough and cold medications that have some serious effects, and if misused, may cause serious harm in infants. It is an increasing health concern but most often neglected in Pakistan as well as other countries. In spite of the worldwide health advisories, including those provided by the FDA with prohibitions issuing such medications to children below two years of age, children are administered cough and cold medications by their parents under ignorance, easy availability, and cultural practices. In fact, research shows that "incidence of accidental and unsupervised ingestion is alarmingly rising". It is caused mainly in children by such effects, leading to symptoms from mild to severe, such as irritability, tachycardia, and even death. This letter underscores the urgency for public health education, regulatory enforcement, and better labeling within the context of protecting vulnerable pediatric subjects from avoidable harm in ways.

Downloads

Published

2025-05-20

Issue

Section

⁠Brief Report / Short Communication